A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example.

T.P. van Staa, H.G.M. Leufkens, B Zhang, L. Smeeth

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to):e1000194
Number of pages1
JournalPLoS Medicine
Volume6
Issue number12
Publication statusPublished - 2009

Keywords

  • Farmacie/Biofarmaceutische wetenschappen (FARM)
  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this